Ibogaine, a psychedelic drug, is being considered as a potential treatment for addiction, including opioid addiction and PTSD. Some US states, including Michigan and Kentucky, are exploring the possibility of advancing research on ibogaine's therapeutic uses. However, the drug's safety is a concern, with reports of deadly outcomes associated with its use.